See today's BioWorld MedTech
To read the full story, subscribe or sign in.

Act Genomics obtains FDA clearance for pan-cancer genomic test

Jan. 13, 2023
By David Ho
Act Genomics (Hong Kong) Ltd. won U.S. FDA approval for its genomic profiling test for solid tumors, Actonco. This marks the first time an Asia-based company has received FDA clearance for a comprehensive genomic profiling test.
BioWorld MedTech Regulatory Cancer Diagnostics U.S.